Posted: 21 October 2011
In Revivo Tea / M Low / 18020 (8 September 2011) the Directorate accepted the respondent’s voluntary undertaking to withdraw or amend its advertising in a manner that addresses the concerns raised by the complainant. The undertaking was accepted for the respondent’s advertising on its website www.revivotea.com which promoted the Revivo Herbal Tea. The issue related to certain testimonials used by the respondent, which made reference to the products effect on the user’s HIV status, their CD4 count and their viral load.
The complainant specifically identified the following examples, which the respondent undertook to remove: “I started using Revivo capsules after I found out I was HIV positive in October last year. In November I bought a bottle. After 3 bottles of one month supply I did a second test for cd4s and viral loads. In October my cd4 was 185 and viral loads was … Read the rest
I am on ARV would like to know if I should use Revivo to boost my immune system and live a better life
@Buti
There is not enough evidence to show that Revivo has any benefits. There is also no evidence to show whether it is safe to use Revivo with ARVs.